These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36078409)

  • 21. Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results.
    Gran G; Aßmus J; Dyrhol-Riise AM
    BMC Public Health; 2013 Apr; 13():353. PubMed ID: 23590619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The usefulness of quantitative interferon-gamma releasing assay response for predicting active tuberculosis in kidney transplant recipients: A quasi-experimental study.
    Kim H; Kim SH; Jung JH; Kim MJ; Kim H; Shin S; Chong YP; Kim YH; Lee SO; Choi SH; Kim YS; Woo JH; Park SK; Han DJ
    J Infect; 2020 Sep; 81(3):403-410. PubMed ID: 32610111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing the cost-effectiveness of two screening strategies for latent tuberculosis infection in Portugal.
    Sousa S; Rocha D; Silva JC; Ribeiro AI; Gonçalves G; Almeida Á; Correia AM; Duarte R; Carvalho C
    Pulmonology; 2021; 27(6):493-499. PubMed ID: 34053903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latent tuberculosis in adult hematopoietic stem cell transplantation recipients: Clinical experience from a previously endemic population.
    Mert D; Ozer M; Merdin A; İskender G; Uncu Ulu B; Kizil Çakar M; Dal MS; Altuntaş F; Ertek M
    Medicine (Baltimore); 2022 Nov; 101(46):e31786. PubMed ID: 36401428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of indeterminate IFN-γ release assay in screening for latent TB in inflammatory bowel diseases.
    Papay P; Eser A; Winkler S; Frantal S; Primas C; Miehsler W; Angelberger S; Novacek G; Mikulits A; Vogelsang H; Reinisch W
    Eur J Clin Invest; 2011 Oct; 41(10):1071-6. PubMed ID: 21413978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of LTBI in patients with autoimmune diseases and accuracy of IGRA in predicting TB relapse.
    Chandrashekara S; Panchagnula R; Chennupati Y
    Rheumatology (Oxford); 2023 Dec; 62(12):3952-3956. PubMed ID: 37348542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberculin test versus interferon gamma release assay in pregnant women with household contacts of tuberculosis patients.
    Chalid MT; Puspawaty D; Tahir AM; Najdah H; Massi MN
    Int J Mycobacteriol; 2022; 11(4):364-370. PubMed ID: 36510919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lessons Learned from Implementation of an Interferon Gamma Release Assay to Screen for Latent Tuberculosis Infection in a Large Multicenter Observational Cohort Study in Brazil.
    Costa AG; Carvalho BKS; Araújo-Pereira M; Ibiapina HNS; Spener-Gomes R; Souza AB; Gomes-Silva A; Andrade AMS; Silva EC; Arriaga MB; Benjamin A; Rocha MS; Moreira ASR; Oliveira JG; Figueiredo MC; Turner MM; Durovni B; Cavalcante S; Kritski AL; Rolla VC; Sterling TR; Andrade BB; Cordeiro-Santos M;
    Microbiol Spectr; 2021 Dec; 9(3):e0116321. PubMed ID: 34851140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased annual risk of tuberculosis infection in South Korean healthcare workers using interferon-gamma release assay between 1986 and 2005.
    Lee EH; Son NH; Kwak SH; Choi JS; Kim MC; Seol CH; Kim SR; Park BH; Kang YA
    BMC Infect Dis; 2021 Nov; 21(1):1161. PubMed ID: 34784896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-gamma release assay.
    Torres Costa J; Sá R; Cardoso MJ; Silva R; Ferreira J; Ribeiro C; Miranda M; Plácido JL; Nienhaus A
    Eur Respir J; 2009 Dec; 34(6):1423-8. PubMed ID: 19948911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Universal screening for latent and active tuberculosis (TB) in asylum seeking children, Bochum and Hamburg, Germany, September 2015 to November 2016.
    Mueller-Hermelink M; Kobbe R; Methling B; Rau C; Schulze-Sturm U; Auer I; Ahrens F; Brinkmann F
    Euro Surveill; 2018 Mar; 23(12):. PubMed ID: 29589578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-γ release assay results.
    Costantino F; de Carvalho Bittencourt M; Rat AC; Loeuille D; Dintinger H; Béné MC; Faure G; Chary-Valckenaere I
    J Rheumatol; 2013 Dec; 40(12):1986-93. PubMed ID: 24085550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of progression to active tuberculosis for indeterminate interferon-gamma release assay in immunocompromised individuals: a systematic review and meta-analysis.
    Zhou G; Luo S; He J; Chen N; Zhang Y; Cai S; Guo X; Song C
    Clin Microbiol Infect; 2023 Nov; 29(11):1375-1384. PubMed ID: 37422080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The incidence of tuberculosis infection in hematopoietic stem cell transplantation recipients: A retrospective cohort study from a center in Turkey.
    Akı ŞZ; Sucak GT; Tunçcan ÖG; Köktürk N; Şenol E
    Transpl Infect Dis; 2018 Aug; 20(4):e12912. PubMed ID: 29679523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of the QuantiFERON-TB Gold interferon-gamma release assay for screening transplant candidates: a single-center retrospective study.
    Theodoropoulos N; Lanternier F; Rassiwala J; McNatt G; Preczewski L; DeMayo E; Stosor V; Ison MG
    Transpl Infect Dis; 2012 Feb; 14(1):1-8. PubMed ID: 21883759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Living donor and recipient screening for latent tuberculosis infection by tuberculin skin test and interferon-gamma releasing assay in a country with an intermediate burden of tuberculosis.
    Moon SM; Park IA; Kim SM; Park SJ; Jung JH; Kim YH; Park JB; Hong B; Lee SO; Choi SH; Kim YS; Woo JH; Park SK; Lee SK; Park JS; Han DJ; Kim SH
    J Infect Chemother; 2013 Oct; 19(5):1009-13. PubMed ID: 23917533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants.
    Campbell JR; Krot J; Elwood K; Cook V; Marra F
    Mol Diagn Ther; 2015 Feb; 19(1):9-24. PubMed ID: 25579159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serial interferon-gamma release assays for the diagnosis of latent tuberculosis infection in patients treated with immunosuppressive agents.
    Kim KH; Lee SW; Chung WT; Kim BG; Woo KS; Han JY; Kim JM
    Korean J Lab Med; 2011 Oct; 31(4):271-8. PubMed ID: 22016681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country.
    Bourgarit A; Baron G; Breton G; Tattevin P; Katlama C; Allavena C; Campa P; Ravaud P; Lortholary O; Carcelain G;
    Ann Am Thorac Soc; 2015 Aug; 12(8):1138-45. PubMed ID: 26213798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detecting Mycobacterium tuberculosis Infection in Children Migrating to Australia.
    Laemmle-Ruff I; Graham SM; Williams B; Horyniak D; Majumdar SS; Paxton GA; Soares Caplice LV; Hellard ME; Trauer JM
    Emerg Infect Dis; 2022 Sep; 28(9):1833-1841. PubMed ID: 35997353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.